Revision history of "Surrogate" (Q27933)

From MaRDI portal

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 April 2024

  • curprev 07:5007:50, 19 April 2024 EloiFerrer talk contribs 62,013 bytes −1,335 Removed claim: Property:P1457: In a clinical trial, it frequently occurs that the most credible outcome to evaluate the effectiveness of a new therapy (the true endpoint) is difficult to measure. In such a situation, it can be an effective strategy to replace the true endpoint by a (bio)marker that is easier to measure and that allows for a prediction of the treatment effect on the true endpoint (a surrogate endpoint). The package 'Surrogate' allows for an evalua...
  • curprev 07:5007:50, 19 April 2024 EloiFerrer talk contribs 63,348 bytes +1,335 Changed an Item

21 March 2024

5 March 2024

4 March 2024

21 February 2024

16 February 2024

9 February 2024

29 January 2024

25 October 2023

4 January 2022